How to manage coagulopathies in critically ill patients

被引：0

作者：

Julie Helms

Toshiaki Iba

Jean Marie Connors

Satoshi Gando

Marcel Levi

Ferhat Meziani

Jerrold H. Levy

机构：

[1] Université de Strasbourg (UNISTRA),Department of Emergency and Disaster Medicine

[2] Faculté de Médecine,Hematology Division

[3] Hôpitaux Universitaires de Strasbourg,Department of Acute and Critical Care Medicine

[4] Service de Médecine Intensive-Réanimation,Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine

[5] Nouvel Hôpital Civil,Department of Vascular Medicine

[6] INSERM (French National Institute of Health and Medical Research),Department of Medicine

[7] UMR 1260,Department of Anesthesiology, Critical Care, and Surgery

[8] Regenerative Nanomedicine (RNM),undefined

[9] FMTS,undefined

[10] Juntendo University Graduate School of Medicine,undefined

[11] Brigham and Women’s Hospital,undefined

[12] Harvard Medical School,undefined

[13] Sapporo Higashi Tokushukai Hospital,undefined

[14] Hokkaido University Faculty of Medicine,undefined

[15] Amsterdam University Medical Centers,undefined

[16] University College London Hospitals NHS Foundation Trust,undefined

[17] and Cardio-Metabolic Programme-NIHR UCLH/UCL BRC London,undefined

[18] Duke University School of Medicine,undefined

来源：

Intensive Care Medicine | 2023年 / 49卷

关键词：

Disseminated intravascular coagulation; Coagulopathy; Sepsis; Trauma; Hematological disease; Critical care;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Coagulopathy is a severe and frequent complication in critically ill patients, for which the pathogenesis and presentation may be variable depending on the underlying disease. Based on the dominant clinical phenotype, the current review differentiates between hemorrhagic coagulopathies, characterized by a hypocoagulable and hyperfibrinolysis state, and thrombotic coagulopathies with a systemic prothrombotic and antifibrinolytic phenotype. We discuss the differences in pathogenesis and treatment of the common coagulopathies.

引用

页码：273 / 290

页数：17

共 50 条

[1] How to manage coagulopathies in critically ill patients
Helms, Julie
Iba, Toshiaki
Connors, Jean Marie
Gando, Satoshi
Levi, Marcel
Meziani, Ferhat
Levy, Jerrold H.
INTENSIVE CARE MEDICINE, 2023, 49 (03) : 273 - 290
[2] Shifting focus: A grounded theory of how family members to critically ill patients manage their situation
Vogel, Gisela
Joelsson-Alm, Eva
Forinder, Ulla
Svensen, Christer
Sandgren, Anna
INTENSIVE AND CRITICAL CARE NURSING, 2023, 78
[3] Corporeal rehabilitation to manage acute stress in critically ill patients
Bourgeon-Ghittori, Irma
Couette, Maryline
Marini, Sylvie
Ouedraogo, Rachida
Alves, Aline
Razazi, Keyvan
Carras, Damien
Pallud, Ann-Cecile
Kentish-Barnes, Nancy
Dessap, Armand Mekontso
ANNALS OF INTENSIVE CARE, 2022, 12 (01)
[4] Corporeal rehabilitation to manage acute stress in critically ill patients
Irma Bourgeon-Ghittori
Maryline Couette
Sylvie Marini
Rachida Ouedraogo
Aline Alves
Keyvan Razazi
Damien Carras
Ann-Cecile Pallud
Nancy Kentish-Barnes
Armand Mekontso Dessap
Annals of Intensive Care, 12
[5] Etiology and treatment of acquired coagulopathies in the critically ill adult and child
Parker, RI
CRITICAL CARE CLINICS, 1997, 13 (03) : 591 - &
[6] How to Measure Pharmacokinetics in Critically Ill Patients?
Liu, Xin
Kruger, Peter S.
Roberts, Michael S.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (12) : 2037 - 2043
[7] How sweet is euglycemia in critically ill patients?
Coursin, DB
Murray, MJ
MAYO CLINIC PROCEEDINGS, 2003, 78 (12) : 1460 - 1462
[8] How to improve enteral nutrition of critically ill patients?
Lichert, Frank
AKTUELLE ERNAHRUNGSMEDIZIN, 2022, 47 (06): : 424 - 424
[9] How to measure energy expenditure in critically ill patients
Marinho, A
Pinho, J
Rocha, A
Oliveira, MM
Oliveira, MG
Brandao, M
INTENSIVE CARE MEDICINE, 2003, 29 : S104 - S104
[10] Nutrition for Critically Ill Patients How Much Is Enough?
Griffiths, Richard D.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (08): : 845 - 846

← 1 2 3 4 5 →